The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLS Days features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Dr. Ulla Aapola

Project Leader, University of Tampere, Spark Finland

Dr. Bertil Abrahamsson

Senior Principal Scientist, AstraZeneca

Dr. Susanna Abrahmsén Alami

Principal Scientist - Drug Delivery, AstraZeneca

Dr. Magnus Aronsen

Project Leader, UiO, Spark Norway

Dr. Ann Atlas

Senior Scientific Advisor Immuno-Oncology and Biomarker Lead, BMS

Mr. Kim Baden-Kristensen

Founder & CEO, Brain+

Mr. David Bejker

CEO, Affibody

Dr. Sonia Benhamida

Senior Vice President Healthcare, DNB

Ms. Johanna Bergh

Partner and European Patent Attorney, AWA

Dr. Christel Bergström

Associate Professor, Uppsala University

Dr. Magnus Björsne

CEO, AstraZeneca BioVentureHub

Mr. Patrick Boisseau

Programme Manager on Nanomedicine, CEA-Leti

Dr. Martin Bonde

CEO, Vaccibody

Mr. Carsten Borring

Head of Listings & Capital Markets, Nasdaq

Dr. Filippo Bosco

Founder & CEO, BluSense Diagnostics

Dr. Mathieu Boudes

Public/Private Partnership Coordinator, European Patients' Forum (EPF)

Ms. Catherine Brett

External Relations Manager, IMI Executive Office

Assoc. Prof. Petter Brodin

Facility Director, SciLifeLab

Ms. Christina Busmalis

Director, Global Life Sciences at IBM Watson Health

Ms. Magda Chlebus

Director Science Policy, EFPIA

Mr. Stephan Christgau

Senior Partner, Novo Seeds

Dr. Scott Cuthill

Chief Business Officer, Valo Therapeutics

Prof. Mark Daly

Director, Institute for Molecular Medicine Finland (FIMM)

Dr. Maureen Deehan

Head of Corporate Development & Strategy, Nordic Nanovector

Dr. Rupert Dixon

Senior Director - Principal Scientific Advisor, IQVIA

Mr. Olivier Duchamp

Managing Director, NLSDays - VP BD & Promotion, SwedenBIO

Dr. Charlotte Edenius

VP Clinical and Business Development, Gesynta Pharma

Mr. Bengt Hedin

Formulation Scientist, APL

Dr. Jonas Ekstrand

Director General, SwedenBIO

Dr. Emilio Erazo-Fischer

Associate Director of Global Oncology BD, Boehringer Ingelheim

Dr. Elin Esbjörner

Associate Professor, Biophysical Chemistry and Biochemistry, Chalmers University

Ms. Ebba Fåhraeus

CEO, SmiLe Incubator

Dr. Marc Gailhardou

Managing Director, MSD Nordics

Mr. Pierre Gareau

Business Development Manager, Servier CDMO

Prof. Craig Garner

Berlin Institute of Health, Founder SPARK Berlin

Ms. Jennifer Grönqvist

Business Advisor HealthTech Nordic, SSP

Dr. Gunnveig Grødeland

Project Leader, UiO, Spark Norway

Ms. Charlotta Gummesson

CEO, Sahlgrenska Science Park

Dr. Sara Gunnerås

Editor, Precision Medicine – The Swedish Industry Guide 2018, SwedenBIO

Mr. Jacob Gunterberg

Partner, HealthCap

Prof. Per Hall

Professor, Karolinska Institutet

Dr. Mats Hansen

CEO, Spago Nanomedical

Ms. Carolina Hawranek

Head of PR and Communications, Umeå Biotech Incubator

Prof. Klaus Hedman

Project Leader, University of Helsinki, Spark Finland

Dr. Minna Hendolin

Senior Director Health & Wellbeing, Business Finland

Mr. Hans Herklots

Managing Director, LifeSci Advisors

Dr. Andreas Hugerth

Senior Product Development Manager, Ferring Pharmaceuticals

Ms. Daniela Ibis

CEO, Daniela Ibis

Dr. Annika Jenmalm-Jensen

Infrastructure Director, SciLifeLab

Dr. Simon S. Jensen

CEO and Co-Founder, MonTa Biosciences

Ms. Hanne-Damgaard Jensen

Founder & CEO, ROS Therapeutics

Ms. Louise Jonshammar

Attorney At Law, AWA

Mr. Magnus Jörntén-Karlsson

Project Director, AstraZeneca R&D

Dr. Stig Jørgensen

Program Director ReproUnion

Dr. Øyvind Kongstun-Arnesen

CEO, Ultimovacs

Prof. Mikael Kubista

CEO and Founder, TATAA BioCenter

Ms. Oxana Kukhaneva

Venture Partner, Seventure Partners

Dr. Shiva Kumar

VP & Chief Strategy Officer, IBM Watson

Mr. Johan Kördel

Senior Partner, Lundbeckfonden Ventures

Dr. Ylva Trolle Lagerros

Associate Professor, Karolinska Institutet

Prof. Ulf Landegren

Facility Director, SciLifeLab

Mr. Magnus Larsson

CEO, Promimic

Dr. Sara Lei

Clinical Advisor, Karolinska University Hospital

Dr. Lasse Leino

CEO, DelSiTech

Ms. Sandra Lindvall

Patent Attorney, Awapatent

Prof. Joakim Lundeberg

Facility Director, SciLifeLab

Assoc. Prof. Tomas Lundqvist

Senior Area Coordinator, RISE Research Institutes of Sweden

Mr. Anders Martin-Löf

CFO, Wilson Therapeutics

Mr. Niklas Mattsson

Partner and European Patent Attorney, AWA

Dr. Helena Nord

Project Leader, SciLifeLab

Dr. Jenni Nordborg

Director & National Coordinator Life Sciences, The Government Offices - Head of Health Division, Vinnova

Dr. Ana Palma

Senior Director Global HTA & Patient Access Lead, Sobi

Dr. Holger Reithinger

Partner, Forbion

Dr. Agneta Richter-Dahlfors

CEO, EBBA Biotech

Dr. Sampo Sammalisto

Advisor HealthTech, Business Finland

Dr. Gunnar Sandberg

Program Director, Vinnova

Dr. Ulrica Sehlstedt

Partner, Arthur D. Little

Mr. Tero Sivola

CEO, BC Platforms

Dr. Eva Sjökvist-Saers

CEO & Managing Director, APL

Dr. Erica Sloan

Group Leader, Cancer & Neural-Immune Research Lab, Monash University

Dr. Patrik Sobocki

Investment Manager, Industrifonden

Dr. Mårten Steen

Partner, HealthCap

Dr. Walter Stockinger

Managing Partner, Hadean Ventures

Ms. Katja Stout

Managing Director, Scius Communications

Mr. Nikolaj Sørensen

CEO & President, Orexo

Ms. Mirka Tammi

Project Director, HUS

Dr. Gaspar Taroncher-Oldenburg

Editor-at-Large, BioPharma Dealmakers & Nature Research Group

Dr. Ingrid Teigland Akay

Managing Partner, Hadean Ventures

Mr. Kristian Thulin

CSO, Obducat Technologies

Dr. Markku Toivonen

Scientific Director, NDA Group

Dr. Anna Törner

Managing Director, Scandinavian Development Services

Dr. Marcel Van Duin

VP, Head Reproductive Health & Endocrinology Research, Ferring Pharmaceuticals

Dr. Rita Vassena

Scientific Director, Eugin, Executive Member of ESHRE

Dr. Sten Verland

Senior Partner, Sunstone Life Science Ventures

Prof. Gunnar Von Heljne

Facility Director, SciLifeLab

Prof. Eric Wahlberg

CEO, Uppsala Academic Hospital

Prof. Marie Wahlgren

Deputy Head, Department of Food Technology, Lund University

Mr. Mike Ward

Chief Content Officer, Informa Pharma Intelligence - Contributor, BioPharma Dealmakers & Nature Research Group

Dr. Richa Wilson

Associate Director, Digital and Personalized Healthcare, Roche Partnering

Mr. Craig Wylie

Partner, Arthur D. Little

Dr. Cheryl Zimberlin

Associate, Merck Ventures

Mr. Martin Åmark

CEO, Xbrane Biopharma